Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
10.9%
0%
10.9%
6 Months
15.11%
0%
15.11%
1 Year
14.91%
0%
14.91%
2 Years
37.56%
0%
37.56%
3 Years
31.07%
0%
31.07%
4 Years
16.22%
0%
16.22%
5 Years
15.31%
0%
15.31%
Cosmo Bio Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.32%
EBIT Growth (5y)
-11.44%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
1.10
Tax Ratio
26.11%
Dividend Payout Ratio
110.99%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.44%
ROE (avg)
6.86%
Valuation key factors
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
0.80
EV to EBIT
15.71
EV to EBITDA
10.56
EV to Capital Employed
0.72
EV to Sales
0.44
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.57%
ROE (Latest)
3.34%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
2,309.00
2,186.00
5.63%
Operating Profit (PBDIT) excl Other Income
40.00
50.00
-20.00%
Interest
0.00
0.00
Exceptional Items
-1.00
-3.00
66.67%
Consolidate Net Profit
35.00
27.00
29.63%
Operating Profit Margin (Excl OI)
0.90%
8.20%
-0.73%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 5.63% vs 9.35% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 29.63% vs -72.45% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
10,037.00
9,340.00
7.46%
Operating Profit (PBDIT) excl Other Income
455.00
669.00
-31.99%
Interest
0.00
0.00
Exceptional Items
-50.00
53.00
-194.34%
Consolidate Net Profit
269.00
461.00
-41.65%
Operating Profit Margin (Excl OI)
31.80%
55.80%
-2.40%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 7.46% vs -2.23% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -41.65% vs -16.49% in Dec 2023
About Cosmo Bio Co., Ltd. 
Cosmo Bio Co., Ltd.
Retailing
No Details Available.
Company Coordinates 
No Company Details Available






